Friday 6-13-2014 Freeport-Mcmoran Copper & Gold (FCX) $FCX

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
Friday 6-13-2014 Freeport-Mcmoran Copper & Gold (FCX) $FCX opened at 33.56 hitting the high price of 34.09 and a day low of 33.39 with a total volume of 6,436,432. FCX had a previous close of 33.67 and has been seeing an average volume of 7,321,080.

Overall Average: 8% Sell

Recent stock forum discussions about FCX http://investorshangout.com/search?q=FCX&...mp;yt0=Go!

Freeport-McMoRan Is Not Immune to Copper Downside
Vladimir Zernov, The Motley Fool - Motley Fool - Fri Jun 13, 12:05PM CDT
Is China's shadow banking system bigger than it seems? It might be, as one of China's biggest ports, Qingdao, starts counting copper and aluminum in warehouses. The investigation started as copper and aluminum could have been used as collateral for... (full story)

Is Freeport-McMoRan Copper & Gold Inc. Destined for Greatness?
Alex Planes, The Motley Fool - Motley Fool - Fri Jun 13, 9:10AM CDT
Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown. The best stocks offer sustainable market-beating gains, with robust and improving financial metrics that support strong price... (full story)

Indonesia's Mining Challenges Are Only Part of the Picture
Joshua Bondy, The Motley Fool - Motley Fool - Fri Jun 13, 8:22AM CDT
It is no secret that the Indonesian government is putting pressure on miners to spend big bucks to develop Indonesian industry. While these political challenges are a headache for miners, the reality is that Indonesia only represents a portion of... (full story)

Watch for Freeport-McMoRan to Potentially Rebound After Falling 1.20% Yesterday
Comtex SmarTrend(R) - Thu Jun 12, 4:20PM CDT
Freeport-McMoRan (NYSE:FCX) traded in a range yesterday that spanned from a low of $33.52 to a high of $34.01. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $33.92 on volume of 7.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. (full story)

Freeport-McMoRan Falls 1.20% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Jun 12, 4:16PM CDT
Freeport-McMoRan (NYSE:FCX) traded in a range yesterday that spanned from a low of $33.52 to a high of $34.01. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $33.92 on volume of 7.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. (full story)

Rowan Companies Shifts to the Deepwaters
Mark Holder, The Motley Fool - Motley Fool - Thu Jun 12, 10:46AM CDT
After decades as an onshore and shallow water drilling specialist, Rowan Companies plc is quickly shifting toward a mix of deepwater drillships. The company has four ultra-deepwater (UDW) drillships either recently starting operations or under... (full story)

Don't Expect Freeport-McMoRan to Follow Newmont's Lead in Indonesia
Rich Duprey, The Motley Fool - Motley Fool - Wed Jun 11, 1:48PM CDT
Newmont Mining's Batu Hijau, Indonesia. Source: Wikimedia Commons. Indonesia has proved to be an immovable force over its export ban on unprocessed ore that was imposed in January, forcing  Newmont Mining to halt further copper output from its... (full story)

Freeport-McMoRan (FCX) Crosses Pivot Point Support at $34.45
Comtex SmarTrend(R) - Tue Jun 10, 10:13AM CDT
Shares of Freeport-McMoRan (NYSE:FCX) have bearishly opened below the pivot of $34.71 today and have reached the first support level of $34.45. Investors may be interested in a cross of the next downside pivot targets of $34.26 and $33.81. (full story)

Rowan Companies Wins Contract from Freeport, Shares Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 10, 9:20AM CDT
Rowan Companies plc's (RDC) share price rose by about 2% following the news of one of its subsidiaries having inked a two-year drilling contract for the fourth and final ultra-deepwater drillship in Rowan's current construction program. (full story)

'Mad Money' Lightning Round: Qualcomm Is a Buy
at The Street - Tue Jun 10, 5:00AM CDT
Cramer likes GenCorp but prefers Alcoa over Freeport-McMoRan. (full story)

Jim Cramer's 'Mad Money' Recap: What Was Jim Cramer Thinking?
at The Street - Mon Jun 09, 7:13PM CDT
The fighting over Hillshire Brands makes Cramer wonder if he hasn't underestimated the valuation of a number of acquisition targets. (full story)

Seadrill Ltd. and its Deepwater Peers Have a Big Week
Matt DiLallo, The Motley Fool - Motley Fool - Mon Jun 09, 10:00AM CDT
Photo credit: Seadrill  Seadrill started June off on a very positive note after the contract driller signed a $1.1 billion five-year contract for its West Jupiter ultra-deepwater drillship. That contract was a sign of good things to come as ... (full story)

Rowan secures fourth USD425m ultra-deepwater drillship deal
M2 - Mon Jun 09, 7:45AM CDT
Drilling company Rowan Companies (NYSE:RDC) reported on Friday the execution of a drilling contract for the Rowan Relentless for operations in the US Gulf of Mexico. (full story)

Rowan wins two-year contract for ultra-deepwater drillship from FM O&G
M2 - Mon Jun 09, 4:02AM CDT
Rowan Companies plc (NYSE:RDC), a provider of contract drilling services, revealed on Friday that one of its subsidiaries has signed a two-year drilling contract for its fourth and final drill-ship in the current construction programme, the Rowan Relentless, with Freeport-McMoRan Oil & Gas LLC (FM O&G), a subsidiary of Freeport-McMoRan Copper & Gold Inc (NYSE:FCX). (full story)

This Re-Emerging American Shale Play Is Perfectly Positioned for LNG Exports
Matt DiLallo, The Motley Fool - Motley Fool - Sun Jun 08, 5:00PM CDT
The natural gas industry and most investors had left the Haynesville Shale for dead. The economics of the natural gas-rich shale play just aren't as good as the Marcellus in an environment where gas prices were low. The economics, however, are... (full story)

Why Rowan Companies (RDC) Stock Is Up Today
at The Street - Fri Jun 06, 1:32PM CDT
Rowan Companies (RDC) is gaining Friday after signing a two-year drilling contract in the Gulf of Mexico with a subsidiary of Freeport-McMoRan Copper & Gold (FCX). (full story)

Rowan Awarded Contract for Fourth Ultra-Deepwater Drillship
PR Newswire - Fri Jun 06, 12:30PM CDT
Rowan Companies plc ("Rowan" or the "Company" (NYSE: RDC) announced today that one of its subsidiaries has entered into a two-year drilling contract for the Rowan Relentless, the fourth and final drillship in Rowan's current construction program. The contract is with Freeport-McMoRan Oil & Gas LLC ("FM O&G" , a subsidiary of Freeport-McMoRan Copper & Gold Inc. (NYSE: FCX), for operations in the U.S. Gulf of Mexico. The contract is expected to commence in the third quarter of 2015 and will add approximately $425 million to Rowan's current contract backlog. (full story)

This Battle Is Extremely Important for Freeport-McMoRan Inc. and Newmont Mining Corp.
Vladimir Zernov, The Motley Fool - Motley Fool - Fri Jun 06, 6:53AM CDT
Five months passed since Indonesia imposed a controversial tax on copper concentrate exports, which forced Freeport-McMoRan and Newmont Mining to halt their exports. Clearly, both Freeport-McMoRan and Newmont Mining cannot pay a 25% export tax,... (full story)

'Fast Money' Recap: Going With the Market's Flow
at The Street - Fri Jun 06, 4:00AM CDT
The trading panel discussed Friday's jobs report, the European Central Bank and where to find quality stocks. (full story)

Freeport-Mcmoran Copper & Gold (FCX) Stock Research Links

FCX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 342

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 178

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 44

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 13

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 292

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 304

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 34

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 363

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 64

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 175

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading

Top 5 Most Recently Viewed Articles

Orion Corporation's Manager Transactions Highlight Executive Moves

Updated Category News Views 133

Understanding Orion Corporation's Executive Transactions Orion Corporation, a prominent player in the global pharmaceutical industry, has recently disclosed significant transactions involving its management, shedding light on financial movements that reflect company growth and strategy. Key Details on Managerial Transactions Recently, Orion Corporation reported under the...

Continue Reading
Congressman Questions SEC's 'Digital Asset Security' Definition

Updated Category News Views 150

Congressman Ritchie Torres Questions SEC's Use of Terminology Representative Ritchie Torres, a Democratic representative from New York, has recently shared his concerns about the phrase "digital asset security" as used by the U.S. Securities and Exchange Commission (SEC). He’s particularly interested in the legal basis and origins of this term. Congressional Dialogue...

Continue Reading
Investigating Claims for StubHub Investors: Your Options

Updated Category News Views 173

Investigation of Claims on Behalf of StubHub Investors Faruqi & Faruqi, LLP, a prominent name in national securities law, is currently looking into potential claims related to StubHub Holdings, Inc. (NYSE: STUB). This initiative aims to assist investors who might have faced losses due to the misleading statements made about the company's financial performance during its...

Continue Reading
Sarepta Therapeutics Faces Class Action Amid Safety Concerns

Updated Category News Views 256

Introduction to Sarepta Therapeutics Sarepta Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative therapies for rare diseases, particularly those associated with genetic factors. The company is well-known for its gene therapy treatments and aims to revolutionize treatment options for patients with Duchenne muscular dystrophy and similar...

Continue Reading